FDA approves first postpartum depression pill

The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.

First Postpartum Depression Pill Becomes Available in the US

FDA approves first postpartum depression pill in the US - KVIA

FDA approves first oral medication for postpartum depression

FDA Approves First Pill To Treat Postpartum Depression - ACHI

Zuranolone: First Oral Medication FDA Approved for Postpartum Depression – Psychiatry Education Forum

Dr Sheryl Ziegler on X: The FDA has greenlit zuranolone, the first-ever oral pill in the U.S. specifically for postpartum depression. This medication offers a beacon of hope, providing more treatment options

Best Encapsulé Royalty-Free Images, Stock Photos & Pictures

FDA approves first postpartum depression pill in U.S. - National

FDA approves first postpartum depression drug

FDA approves oral medicine to treat ``postpartum depression'' that develops symptoms of depression after childbirth - GIGAZINE

FDA approves first postpartum depression pill

FDA Approves First Pill for Postpartum Depression - Women's Healthcare

FDA Approves First Oral Treatment for Postpartum Depression - US FDA

Austin area woman among first to receive FDA-approved postpartum depression treatment